New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
aTyr Pharma, Inc. (ATYR) vs Palatin Technologies, Inc. (PTN)
- aTyr Pharma, Inc. ATYR 3.82 +3.52%
- Palatin Technologies, Inc. PTN 4.58 −7.10%
aTyr Pharma, Inc. and Palatin Technologies, Inc. are both Biotechnology companies. aTyr Pharma, Inc. and Palatin Technologies, Inc. are of similar size ($9.0M and $8.8M). aTyr Pharma, Inc. has the higher net margin (−155.2% vs −385.4%) and the higher return on invested capital (0.00% vs 0.00%). Across the 14 metrics below, aTyr Pharma, Inc. leads on 9 and Palatin Technologies, Inc. on 5.
Valuation
Profitability
| Metric | ATYR | PTN | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 70.18% |
| Operating margin | (152.19%) | (392.22%) | 0.00% |
| Net margin | (155.18%) | (385.44%) | 0.00% |
| Free cash flow margin | (148.11%) | (333.15%) | 0.00% |
| Return on equity | (93.69%) | (1,495.52%) | (51.58%) |
| Return on assets | (64.07%) | (271.70%) | (45.91%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack